Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from MIDAC HOLDINGS CO. LTD. ( (JP:6564) ).
Midac Holdings has finalized the remaining terms of a previously approved stock option program, setting detailed conditions for stock acquisition rights to be granted to employees of the parent company and its subsidiaries. The plan covers 120 employees across the group and authorizes 284 stock acquisition rights tied to 28,400 shares of common stock, with an exercise price of 2,057 yen per share, aligning employee incentives with the company’s equity performance and potentially diluting existing shareholders on a limited scale.
Under the finalized terms, 30 employees at the parent company will receive 78 units of stock acquisition rights, while 90 subsidiary employees will receive 206 units, reinforcing group-wide alignment of interests. By implementing this stock-based compensation scheme, Midac is signaling a continued focus on employee motivation and long-term value creation, which may support talent retention and strengthen its competitive positioning in the market.
The most recent analyst rating on (JP:6564) stock is a Hold with a Yen2241.00 price target. To see the full list of analyst forecasts on MIDAC HOLDINGS CO. LTD. stock, see the JP:6564 Stock Forecast page.
More about MIDAC HOLDINGS CO. LTD.
Midac Holdings Co., Ltd. is a Japan-listed company on the Tokyo Stock Exchange Prime Market and the Nagoya Stock Exchange Premier Market, operating through the parent company and its subsidiaries. The group employs a sizable workforce eligible for equity-based incentives, reflecting a corporate structure that uses stock options as part of its human capital and retention strategy.
Average Trading Volume: 68,703
Technical Sentiment Signal: Buy
Current Market Cap: Yen53.97B
Learn more about 6564 stock on TipRanks’ Stock Analysis page.

